Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced its ...

Key Insights Significantly high institutional ownership implies Ginkgo Bioworks Holdings' stock price is sensitive ...

Cathie Wood, the founder of Ark Invest, is under intense pressure as most of her ETFs implode. The Ark Innovation Fund (ARKK) ...

Enter Ginkgo Bioworks, a company that aims to “make biology easier to engineer.” The company harnesses the power of AI and robotics to automate complex biological tasks. It's a holding in the ...

A partnership between Davidson College and Green Legacy Hiroshima brings Gingko trees to campus that are descendents of trees ...

Novo Nordisk and Ginkgo Bioworks will work together on manufacturing. Producing more obesity and diabetes medicines is likely a priority. But there could be challenges, especially for the smaller ...

Renowned for centuries, Ginkgo biloba is a well-known herbal supplement famed for its potential to bolster cognitive function, memory, and overall brain health. Sourced from the leaves of the ...

Ginkgo Bioworks (NYSE: DNA) of Boston has acquired the platform assets of AgBiome. This includes a massive microbial strain library, millions of unique gene sequences and AgBiome's development ...

Teddy Bear southern magnolia. If you like the stately look of this traditional tree of the South, but you need one that won’t ...

BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's ...

We live in the age of the elevator pitch, catchy soundbites, and companies promising to revolutionize every industry under ...